Avanos Medical, Inc.
AVNS
$11.44
-$0.14-1.21%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.70% | 1.48% | 1.34% | 2.15% | -0.01% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.70% | 1.48% | 1.34% | 2.15% | -0.01% |
| Cost of Revenue | 10.16% | 6.04% | 5.35% | 4.39% | 3.13% |
| Gross Profit | -3.28% | -2.13% | -1.77% | 0.42% | -2.40% |
| SG&A Expenses | 3.04% | 2.30% | -2.18% | -1.94% | -6.36% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -14.81% | -113.95% | -47.83% | -9.09% | 0.00% |
| Total Operating Expenses | 5.71% | 3.03% | 0.96% | 0.89% | -2.02% |
| Operating Income | -45.16% | -21.68% | 8.41% | 37.18% | 48.16% |
| Income Before Tax | -1,969.35% | -3,508.57% | -14,733.33% | -5,005.06% | 1,144.00% |
| Income Tax Expenses | -538.64% | -327.14% | -446.51% | -950.00% | -49.43% |
| Earnings from Continuing Operations | -2,259.45% | -6,690.00% | -23,662.50% | -3,802.02% | 293.75% |
| Earnings from Discontinued Operations | 95.00% | -371.43% | 92.74% | 88.82% | 86.43% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3,086.62% | -6,115.58% | -518.33% | -534.47% | 128.34% |
| EBIT | -45.16% | -21.68% | 8.41% | 37.18% | 48.16% |
| EBITDA | -27.84% | -11.11% | 4.92% | 15.99% | 18.73% |
| EPS Basic | -3,090.51% | -6,091.07% | -530.36% | -546.92% | 128.82% |
| Normalized Basic EPS | -48.92% | -20.27% | 41.65% | 122.03% | 120.02% |
| EPS Diluted | -3,197.02% | -6,306.59% | -530.44% | -545.74% | 127.74% |
| Normalized Diluted EPS | -48.87% | -20.61% | 41.13% | 122.74% | 120.79% |
| Average Basic Shares Outstanding | 0.27% | -0.38% | -1.08% | -1.23% | -1.29% |
| Average Diluted Shares Outstanding | -0.38% | -0.38% | -0.64% | -0.64% | -0.53% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |